Lauren Evans

Lauren Evans has a long history of experience in the scientific field. In 2021, they began working at Eikonizo Therapeutics as a Scientist II and Scientist I. In 2020, they worked as a Research Intern at NextCure, Inc. From 2016 to 2020, they were a Graduate Student at Johns Hopkins Medicine, working in the lab of Dr. Andrew Holland and utilizing a CRISPR/Cas9 genome-wide screen to develop a KO mouse model to analyze the role of centriole amplification in cell growth and tumorigenesis. This work was funded by a NSF GRFP fellowship. From 2014 to 2016, they were an Undergraduate Student Researcher at Roswell Park Comprehensive Cancer Center, working in the lab of Dr. Elizabeth Repasky and developing in vitro and in vivo systems to investigate the role of B-adrenergic signaling in the response of tumor cells to chemotherapy and radiation. From 2013 to 2014, they were an Undergraduate Student Researcher at Canisius College, working in the lab of Dr. Sarah Evans and studying the DNA binding properties of the BosR transcription factor of B. burgdorferi and examining metal cofactors that act to competitively inhibit the interaction of BosR with DNA.

Lauren Evans completed their Bachelor of Science in Biochemistry from Canisius College in 2016. Lauren then went on to pursue a Doctor of Philosophy in Molecular Genetics from The Johns Hopkins University School of Medicine, which they are expected to complete in 2022.